RUNDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.724450E-01
Normal-vs-Stage2
9.413000E-01
Normal-vs-Stage3
5.696400E-02
Normal-vs-Stage4
2.340200E-01
Stage1-vs-Stage2
1.893570E-02
Stage1-vs-Stage3
6.221000E-03
Stage1-vs-Stage4
6.293200E-01
Stage2-vs-Stage3
3.014100E-02
Stage2-vs-Stage4
1.764620E-01
Stage3-vs-Stage4
5.936000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.085800E-01
Normal-vs-AfricanAmerican
5.153800E-01
Normal-vs-Asian
9.565000E-01
Caucasian-vs-AfricanAmerican
7.609800E-01
Caucasian-vs-Asian
5.848400E-01
AfricanAmerican-vs-Asian
4.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.836200E-01
Normal-vs-Female
8.528800E-01
Male-vs-Female
7.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.090800E-01
Normal-vs-Age(41-60Yrs)
6.556000E-01
Normal-vs-Age(61-80Yrs)
9.321600E-01
Normal-vs-Age(81-100Yrs)
8.791600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.917500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.495600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.553800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.255800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.855200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.085800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.386200E-01
Normal-vs-Daily Drinker
9.629200E-01
Normal-vs-Weekly Drinker
8.458600E-01
Normal-vs-Occasional Drinker
4.555800E-01
Normal-vs-Social Drinker
5.739200E-01
Non Drinker-vs-Daily Drinker
7.937400E-01
Non Drinker-vs-Weekly Drinker
8.536000E-01
Non Drinker-vs-Occasional Drinker
7.228500E-02
Non Drinker-vs-Social Drinker
1.735400E-01
Daily Drinker-vs-Weekly Drinker
6.705600E-01
Daily Drinker-vs-Occasional Drinker
1.201820E-01
Daily Drinker-vs-Social Drinker
2.519800E-01
Weekly Drinker-vs-Occasional Drinker
9.754000E-02
Weekly Drinker-vs-Social Drinker
1.944810E-01
Occasional Drinker-vs-Social Drinker
7.881000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.304100E-02
Normal-vs-Grade 2
2.384300E-03
Normal-vs-Grade 3
1.740350E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.751560E-01
Grade 1-vs-Grade 3
1.832570E-01
Grade 1-vs-Grade 4
6.304100E-02
Grade 2-vs-Grade 3
9.848600E-01
Grade 2-vs-Grade 4
2.384300E-03
Grade 3-vs-Grade 4
1.740350E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.953400E-01
Normal-vs-NonDiabetic
7.014400E-01
Diabetic-vs-NonDiabetic
1.114240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.198200E-01
Normal-vs-NoPancreatitis
8.587400E-01
Pancreatitis-vs-NoPancreatitis
4.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.926400E-01
Normal-vs-N1
9.509600E-01
N0-vs-N1
1.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.267200E-01
Normal-vs-TP53-NonMutant
5.024000E-01
TP53-Mutant-vs-TP53-NonMutant
1.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
